Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;55(2):2241351.
doi: 10.1080/07853890.2023.2241351.

Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study

Michel Najjar  1 , Sara Albuaini  1 , Mohammad Fadel  1 , Fatema Mohsen  1 ; Data Collection Group; Georjena Najjar, Dona Assaf, Ahmad Aljbawi, Yara AlAwad
Affiliations

Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study

Michel Najjar et al. Ann Med. 2023.

Abstract

Introduction: Studying post-vaccination side effects and identifying the reasons behind low vaccine uptake are pivotal for overcoming the pandemic.

Methods: This cross-sectional study was distributed through social media platforms and face-to-face interviews. Data from vaccinated and unvaccinated participants were collected and analyzed using the chi-square test, multivariable logistic regression to detect factors associated with side effects and severe side effects.

Results: Of the 3509 participants included, 1672(47.6%) were vaccinated. The most common reason for not taking the vaccine was concerns about the vaccine's side effects 815(44.4). The majority of symptoms were mild 788(47.1%), followed by moderate 374(22.3%), and severe 144(8.6%). The most common symptoms were tiredness 1028(61.5%), pain at the injection site 933(55.8%), and low-grade fever 684(40.9%). Multivariable logistic regression analysis revealed that <40 years (vs. ≥40; OR: 2.113, p-value = 0.008), females (vs. males; OR: 2.245, p-value< .001), did not receive influenza shot last year (vs. did receive Influenza shot last year OR: 1.697, p-value = 0.041), AstraZeneca (vs. other vaccine brands; OR: 2.799, p-value< .001), co-morbidities (vs. no co-morbidities; OR: 1.993, p-value = 0.008), and diabetes mellitus (vs. no diabetes mellitus; OR: 2.788, p-value = 0.007) were associated with severe post-vaccine side effects. Serious side effects reported were blood clots 5(0.3%), thrombocytopenia 2(0.1%), anaphylaxis 1(0.1%), seizures 1(0.1%), and cardiac infarction 1(0.1%).

Conclusion: Our study revealed that most side effects reported were mild in severity and self-limiting. Increasing the public's awareness of the nature of the vaccine's side effects would reduce the misinformation and improve the public's trust in vaccines. Larger studies to evaluate rare and serious adverse events and long-term side effects are needed, so people can have sufficient information and understanding before making an informed consent which is essential for vaccination.

Keywords: War; adverse effects; crisis; immunization; low-income.

Plain language summary

Age < 40 years, females, not receiving influenza shot, AstraZeneca vaccine, co-morbidities, and diabetes mellitus were factors significantly associated with severe post-vaccination side effects.Although most of the reported vaccine side effects were mild in severity and well-tolerated, larger prospective studies to understand the causes of rare serious adverse events and long-term side effects are needed to overcome vaccine hesitancy among people and enable them to have sufficient information and understanding before making an informed consent which is essential for vaccination.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
(A to L) Shows the side effect severity after receiving each dose.
See this image and copyright information in PMC

References

    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):1–14. doi: 10.1016/s0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Han E, Tan MMJ, Turk E, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020;396(10261):1525–1534. doi: 10.1016/s0140-6736(20)32007-9. - DOI - PMC - PubMed
    1. Farrar c. A race for the covid-19 vaccine: a story of innovation and collaboration 2020. Available from: https://www.carnallfarrar.com/a-race-for-the-covid-19-vaccine-a-story-of.... accessed 24 November 2020.
    1. BIO SJASoC-VwWEPEP . Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process WHO2021 [updated 07 July 2022. Available from: https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVI....
    1. pandem-ic . Mapping our unvaccinated world: pandem-ic; 2022. Available from: https://pandem-ic.com/mapping-our-unvaccinated-world/. accessed September 12, 2022 2022.

Substances